1-3 of 3
Hiroki Kobayashi
Close
Sort by
Journal Articles

Distribution and clinical impact of molecular subtypes with dark zone signature of DLBCL in a Japanese real-world study

Tomohiro Urata, Yusuke Naoi, Aixiang Jiang, Merrill Boyle, Kazutaka Sunami, Toshi Imai, Yuichiro Nawa, Yasushi Hiramatsu, Kazuhiko Yamamoto, Soichiro Fujii, Isao Yoshida, Tomofumi Yano, Ryota Chijimatsu, Hiroyuki Murakami, Kazuhiro Ikeuchi, Hiroki Kobayashi, Katsuma Tani, Hideki Ujiie, Hirofumi Inoue, Shuta Tomida, Akira Yamamoto, Takumi Kondo, Hideaki Fujiwara, Noboru Asada, Hisakazu Nishimori, Keiko Fujii, Nobuharu Fujii, Ken-ichi Matsuoka, Keisuke Sawada, Shuji Momose, Jun-ichi Tamaru, Asami Nishikori, Yasuharu Sato, Tadashi Yoshino, Yoshinobu Maeda, David W. Scott, Daisuke Ennishi
Journal: Blood Advances
Blood Adv (2023) 7 (24): 7459–7470.
https://doi.org/10.1182/bloodadvances.2023010402
Published: 2023
Includes: Supplemental data
Journal Articles

Left ventricular diastolic function as a possible predictor of severe carfilzomib-induced cardiovascular events

Clinical Trials & Observations
Yoshiaki Abe, Tetsuya Kobayashi, Kentaro Narita, Hiroki Kobayashi, Akihiro Kitadate, Daisuke Miura, Masami Takeuchi, Kosei Matsue
Journal: Blood Advances
Blood Adv (2019) 3 (11): 1725–1728.
https://doi.org/10.1182/bloodadvances.2019000247
Published: 2019
Includes: Supplemental data
Journal Articles

Prognostic significance of bone marrow abnormalities in the appendicular skeleton of patients with multiple myeloma

Clinical Trials & Observations
Kosei Matsue, Hiroki Kobayashi, Yuya Matsue, Yoshiaki Abe, Kentaro Narita, Akihiro Kitadate, Masami Takeuchi
Journal: Blood Advances
Blood Adv (2018) 2 (9): 1032–1039.
https://doi.org/10.1182/bloodadvances.2017014720
Published: 2018
Includes: Supplemental data